PIK3CA and breast carcinoma: In this study, clinical samples treated prospectively together with in vitro functional studies concordantly show simvastatin to induce apoptosis, suppress proliferation and dephosphorylate sequential signalling cascades of PI3K/Akt/mTOR and MAPK/ERK pathways of breast cancer.